Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#30 in St. Laurent
#3,464 in Canada
Targanta Therapeutics, Inc.
Forward Citations = 6
16 inventors:
Targanta Therapeutics, Inc.
% Expired Patents = 50.0
CIPO Patents = 5
EPO Patents = 1
Forward Citations = 6
Loading Chart...
Loading Chart...
16 inventors (with patents filed for the assignee):
Jerry Pelletier (3 out of 4 patents)
Philippe Gros (3 out of 4 patents)
Michael DuBow (2 out of 2 patents)
4. Evelyne Dietrich (1 out of 12 patents)
5. Adel Rafai Far (1 out of 13 patents)
6. Ranga Reddy (1 out of 4 patents)
7. Stephane Ciblat (1 out of 2 patents)
8. Ting Kang (1 out of 3 patents)
9. Yannick Stephane Rose (1 out of 1 patent)
10. Yanick Lafontaine (1 out of 1 patent)
11. Dominique Bergeron (1 out of 4 patents)
12. Mike DuBow (1 out of 2 patents)
13. Gregory Moeck (6 patents)
14. Dario Lehoux (6 patents)
15. Mark Harvey Wilcox (3 patents)
4 patents:
Company Overview
Targanta Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative antibiotics to treat serious infections. The company is dedicated to addressing the growing problem of antibiotic resistance and providing new treatment options for patients in need.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Targanta Therapeutics, Inc.. Retrieved from https://idiyas.com/company/targanta-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]